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OVERVIEW
Lower respiratory infections (LRI) , refer to  a broad category of 
diseases , that  involve the lower respiratory tract which comprises 
the  trachea (wind-pipe), bronchial tubes, bronchioles or lungs. 
Figure 1   Respiratory Tract
 Examples of LRI are pneumonia, bronchitis, bronchiolitis and 
croup. Croup, which is an illness of the larynx (upper respiratory 
region), is considered an LRI as consequences of its infection often 
spread to the lower respiratory tract. 
 LRI is a major threat to children’s health everywhere as children 
are the most susceptible group infected (Brodzinki H, 2009).It is 
reported that the highest incidence of respiratory infection occurs 
during the first year of life, where infants and children less than five 
years of age would experience 3 – 11 episodes of acute respiratory 
infection. Ninety-eight percent of all respiratory death is related to 
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infection of the lower respiratory tract:  42 % of these deaths are due 
to pneumonia occurring in children less than 5 years of age. Out of 
these childhood deaths, 95% occur among children living in the less 
developed parts of the world. The situation is dire in these regions 
as poor nutrition is prevalent and access to health care is scare or 
limited. It remains the common cause for emergency department 
visits and hospitalization (Osterhaus AD, 2008). As such, it is the 
number one cause of death in the developing world.  
 For treatment purpose of each of these illnesses, it is important at 
the onset to identify the causative agent of the infection.  For example, 
in pneumonia, it is important   to differentiate viral or bacterial 
infection. Of bacterial infection, it could be due to Streptococcus 
pneumoniae, Haemophilus influenzae, Staphylococcus aureus and 
Streptococus pyrogenes. If a viral infection is suspected, of which 
it could be Respiratory syncytial virus (RSV), metapneumovirus, 
parainfluenza, or adenovirus,  then no  antibiotics is administered 
since such prescription would not have any effect on virus.  This 
is also to prevent resistance of antibiotics by organisms, to reduce 
overall reduction of antibiotics use and lastly to control any infection 
during hospital stay or nosocomial transmission. (Pavia AT et al, 
2011).
 The next section would look at the specific illness of each of 
the above LRI, that being, pneumonia, bronchiolitis, bronchitis and 
croup respectively.
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PNEUMONIA
Pneumonia is a common infection that affects many infants (young 
children between the ages of 1 month to 12 months) and children. 
According to the World Health Organization (WHO), over two 
million children die from this infection each year (Rec, 2007). In 
2008, pneumonia killed more children than other diseases, measles, 
malaria and Aids, combined. Pneumonia accounts for one out of 
five under five deaths in the developing world. It is the third leading 
cause of death accounting for over 1.9 million deaths annually in 
children below 5 years of age. Worldwide, pneumonia accounts for 
19 percent of all under five deaths where 26 % of this is of neonatal 
deaths (Bull, 2008).
 The lungs are composed of thousands of tubes (bronchi) that 
are subdivided into smaller airways (bronchioles), which end in 
these small sacs, alveoli (Figure 2).  The alveoli contain capillaries 
where oxygen is added to the blood and carbon dioxide is removed.
Figure 2  Pneumonia affects the alveoli 
 When a person has pneumonia, pus and fluid fill the alveoli in 
one or both lungs, which interfere with oxygen absorption, making 
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breathing difficult. This condition will result in the inflammation 
of the lungs affecting the microscopic small air sacalveolars. Most 
acute respiratory infections result in mild illnesses, such as the 
common cold. But in vulnerable children, infections that begin with 
mild symptoms may sometimes lead to more severe illnesses, such 
as pneumonia – especially when they coincide with other illnesses 
like diarrhea and malaria.
Figure 3  Differences between a normal alveolar and pneumonia 
infected
How is Pneumonia Transmitted? 
Children are susceptible to infection when they have weak immunity 
system (as in immunocompromised patients). However, in a 
community –acquired pneumonia, children are infected via air-
borne or aerosol droplets or through contact (fomites).
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 Multiple microbes cause LRI in infants and children, and 
establishing microbial diagnosis is difficult. In children, 85 % 
is caused by co-infection of bacteria and viruses. Investigations 
to detect the etiology involved performing multiple laboratory 
tests, some only available in research laboratories. For some 
organisms, particularly viruses, Mycoplasma and chlamydiaceae, 
microbial etiology is inferred by detection of microorganisms in 
the upper respiratory tract.  For others, serologic tests or nucleic 
assay (polymerase chain reaction) is the preferred method. Certain 
bacteria are present as the normal upper respiratory flora. Bacteremia 
(presence of bacteria in blood) confirms the cause but is present 
in only 1-10% of hospitalized children with pneumonia.  In most 
cases, extensive or invasive testing is not warranted. Among the 
viruses the most common is RSV. The leading cause of pneumonia 
in children of the developing countries is S.pneumoniae followed 
by another bacterial pathogen, Hinfluenzae type b (Hib). With the 
introduction of Hib vaccine in the 1990’s, Hib cases have been 
on the decline. Clinical presentations and agents of pneumonia in 
infants and children differ from adults.  As shown in the following 
table (Table 1), there are various microbes causing pneumonia.
❚❘❘ 6
Lower Respiratory Infections in Children
T
ab
le
 1
   
 M
ic
ro
bi
al
 C
au
se
s 
of
 C
om
m
un
it
y-
A
cq
ui
re
d 
P
ne
um
on
ia
 in
 C
hi
ld
ho
od
A
ge
E
ti
ol
og
ic
 a
ge
nt
s
C
lin
ic
al
 F
ea
tu
re
s
B
ir
th
 –
 3
 w
ks
(N
eo
na
te
s-
ag
e 
le
ss
 th
an
 o
ne
-
m
on
th
 o
ld
 )
G
ro
up
 B
 S
tr
ep
to
co
cu
s
Pa
rt
 o
f 
ea
rl
y-
on
se
t s
ep
ti
ce
m
ia
; u
su
al
ly
 s
ev
er
e
G
ra
m
-n
eg
at
iv
e 
en
te
ri
c 
ba
ci
ll
i
Fr
eq
ue
nt
ly
 n
os
oc
om
ia
l;
 o
cc
ur
s 
in
fr
eq
ue
nt
ly
 w
it
hi
n 
1 
w
ee
k 
of
 b
ir
th
C
yt
om
eg
al
ov
ir
us
Pa
rt
 o
f 
sy
st
em
ic
 c
yt
om
eg
al
ov
ir
us
 in
fe
ct
io
n.
 P
ar
t o
f 
ea
rl
y-
on
se
t 
se
pt
ic
em
ia
L
is
te
ri
a 
m
on
oc
yt
og
en
es
Pa
rt
 o
f 
di
ss
em
in
at
ed
 in
fe
ct
io
n
H
er
pe
s 
si
m
pl
ex
 v
ir
us
Pa
rt
 o
f 
co
ng
en
it
al
 s
yn
dr
om
e
Tr
ep
on
em
ap
al
li
du
m
Fr
om
 m
at
er
na
l g
en
it
al
 in
fe
ct
io
n:
 a
fe
br
il
e 
pn
eu
m
on
ia
G
en
it
al
 M
yc
op
la
sm
a 
or
 
U
re
ap
la
sm
a
Fr
om
 m
at
er
na
l g
en
it
al
 in
fe
ct
io
n:
 a
fe
br
il
e,
su
ba
cu
te
, i
nt
er
st
it
ia
l 
pn
eu
m
on
ia
3 
w
ks
-3
 m
th
s
(I
nf
an
ts
)
C
hl
am
yd
ia
 tr
ac
ho
m
at
is
Fr
om
 m
at
er
na
l g
en
it
al
  i
nf
ec
ti
on
 ; 
af
eb
ri
le
, s
ub
ac
ut
e,
 in
te
rs
ti
ti
al
 
pn
eu
m
on
ia
R
es
pi
ra
to
ry
 s
yn
cy
ti
al
 v
ir
us
 
(R
S
V
)
Pe
ak
 in
ci
de
nc
e 
at
 2
-7
 m
on
th
s 
of
 a
ge
; u
su
al
ly
 w
he
ez
in
g 
il
ln
es
s 
(b
ro
nc
hi
ol
it
is
/p
ne
um
on
ia
)
Pa
ra
in
fl
ue
nz
av
ir
us
es
,e
sp
ec
ia
lly
 
ty
pe
 3
S
im
il
ar
 to
 R
S
V,
 b
ut
 s
li
gh
tly
 o
ld
er
 in
fa
nt
s 
an
d 
no
t  
ep
id
em
ic
 in
 
w
in
te
r
St
re
pt
oc
oc
us
pn
eu
m
on
ia
e
M
os
t c
om
m
on
 c
au
se
 o
f 
ba
ct
er
ia
l p
ne
um
on
ia
B
or
de
te
ll
a 
pe
rt
us
si
s
P
ri
m
ar
ily
 c
au
se
s 
br
on
ch
it
is
; s
ec
on
da
ry
 b
ac
te
ri
al
 p
ne
um
on
ia
 a
nd
 
pu
lm
on
ar
y 
hy
pe
rt
en
si
on
 c
an
 c
om
pl
ic
at
e 
se
ve
re
 c
as
es
7 ❘❘❚ 
Norlijah Othman
3 
m
th
s 
– 
5 
yr
s
(C
hi
ld
re
n)
R
S
V,
 p
ar
ai
nfl
ue
nz
a,
 in
fl
ue
nz
a,
 
m
et
ap
ne
um
ov
ir
us
,a
de
no
vi
ru
s,
r
hi
no
vi
ru
s
M
os
t c
om
m
on
 c
au
se
 o
f 
 p
ne
um
on
ia
St
re
pt
oc
oc
cu
s 
pn
eu
m
on
ia
e
M
os
t l
ik
el
y 
ca
us
e 
of
 lo
ba
r 
pn
eu
m
on
ia
; i
nc
id
en
ce
 m
ay
 b
e 
de
cr
ea
si
ng
 a
ft
er
 v
ac
ci
ne
 u
se
.
H
ae
m
op
hi
lu
si
nfl
ue
nz
ae
Ty
pe
 b
 u
nc
om
m
on
 w
it
h 
va
cc
in
e 
us
e;
 n
on
-t
yp
ab
le
 s
ta
in
s 
ca
us
e 
pn
eu
m
on
ia
 in
 im
m
un
oc
om
pr
om
is
ed
  h
os
ts
 a
nd
  i
n 
de
ve
lo
pi
ng
 
co
un
tr
ie
s
St
ap
hy
lo
co
cc
us
 a
ur
eu
s
U
nc
om
m
on
, a
lt
ho
ug
h 
co
m
m
un
it
y 
ac
qu
ir
ed
 (
C
A
)-
M
R
S
A
 is
 
be
co
m
in
g 
m
or
e 
pr
ev
al
en
t
M
yc
op
la
sm
a 
pn
eu
m
on
ia
e
C
au
se
s 
pn
eu
m
on
ia
 p
ri
m
ar
ily
 in
 c
hi
ld
re
n 
ov
er
 4
 y
ea
rs
 o
f 
ag
e.
M
yc
ob
ac
te
ri
um
 tu
be
rc
ul
os
is
M
aj
or
 c
on
ce
rn
 w
it
h 
ch
il
dr
en
 o
f 
hi
gh
 p
re
va
le
nc
e 
an
d 
in
 c
hi
ld
re
n 
w
it
h 
H
IV
5-
15
 y
rs
(C
hi
ld
re
n-
A
do
le
sc
en
t)
M
yc
op
la
sm
a 
pn
eu
m
on
ia
e
M
aj
or
 c
au
se
 o
f 
pn
eu
m
on
ia
 ,v
ar
ia
bl
e 
ch
es
t-
xr
ay
 a
pp
ea
ra
nc
e
C
hl
am
yd
op
hi
la
pn
eu
m
on
ia
e
C
on
tr
ov
er
si
al
, b
ut
 p
ro
ba
bl
y 
an
 im
po
rt
an
t c
au
se
 in
 o
ld
er
 c
hi
ld
re
n 
in
 
th
is
 a
ge
 g
ro
up
❚❘❘ 8
Lower Respiratory Infections in Children
 Some believe that common bacterial pathogens causing 
pneumonia are often already present in a child’s nose or throat (this 
is referred as colonization in medical term) and are then inhaled 
into the lungs, causing infection. Pathogens may also be spread 
through contaminated air droplets or may result from blood-borne 
infections. During or shortly after birth, babies are at higher risk of 
developing pneumonia from coming into contact with organisms in 
the birth canal or from contaminated substances contacted during 
delivery.
 Children with pneumonia may have a range of symptoms 
depending on their age and the cause of the infection. Bacterial 
pneumonia usually causes children to become severely ill with high 
fever and rapid breathing. Viral infections, however, often come on 
gradually and may worsen over time.
 Some common symptoms of pneumonia in children and infants 
include rapid or difficult breathing, cough, fever, chills, headaches, 
loss of appetite and wheezing. Children under five with severe cases 
of pneumonia may struggle to breathe, with their chests moving 
in or retracting during inhalation (known as ‘lower chest wall in 
drawing’). Young infants may suffer convulsions, unconsciousness, 
hypothermia, lethargy and feeding problems.
 Since it is difficult to prove the etiological agent of LRI, 
antimicrobial therapy is empiric. As viral LRI is more frequent in 
healthy children, no antibiotic is given unless otherwise proven. In 
neonates, antibiotic such as cefotaxime is administered since the 
pathogens are similar to that of sepsis.  The use of antiviral therapy 
depends on pathogens, the severity of the clinical course and the 
availability of effective non- toxic therapy. 
 Vaccines may help prevent pneumonia in children and this 
depends on the pathogen. Ribavirin has been given to some 
children younger than 24 months to prevent pneumonia caused 
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by RSV though its use has been questioned. Flu vaccine prevents 
pneumonia and other problems caused by the influenza virus. This 
influenza vaccine must be given each year to protect against new 
virus strains. Hib vaccine prevents pneumonia in children from Hib. 
Pneumococcal vaccine prevents pneumonia from S. pneumoniae. 
BRONCHIOLITIS
Bronchiolitis is an acute infectious disease of the lower respiratory 
tract that occurs primarily in young infants, most often in those aged 
2-24 months. Day-care attendance and exposure to cigarette smoke 
can increase the likelihood of an infant to develop bronchiolitis.
 Among the developed countries, the frequency of bronchiolitis 
appears to be similar. However epidemiologic data for underdeveloped 
countries is incomplete. Peak incidence of bronchiolitis usually 
occurs during winter months in temperate climates and during the 
rainy season in tropical climates. RSV infection is most widespread 
during the winter.  The number of   cases of bronchiolitis occurring 
during summer and early fall is less and they are more likely caused 
by rhinovirus or parainfluenza virus.
 Eighty percent of bronchiolitis are due primarily to RSV,  the 
most common pathogen worldwide. More than half of all infants 
are exposed to this virus by their first birthday. Other common 
viruses that can cause bronchiolitis include adenovirus, human 
metapneumovirus, influenza and parainfluenza virus type 3. The 
less common causes include B. pertussis, M.pneumoniae, measles, 
influenza and adenovirus. Adenovirus has been associated with a 
severe form of bronchiolotis, bronchiolitis obliterans.  
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Figure 4  In bronchiolitis, the airway becomes obstructed from swelling 
of the bronchiole walls
 Bronchiolitis causes the inflammation (swelling) of the 
bronchioles, the smallest passage of the lungs (Figure 4). Infants are 
more likely to be infected as their airways are smaller than the older 
children and so are more easily blocked. The swollen bronchioles, 
filled with mucus, will obstruct the airway passage and these results 
in the symptoms it presents:  coughing, wheezing and shortness of 
breath. 
 Bronchiolitis represents itself as late stage of respiratory disease 
that progresses over several days.  Upper respiratory tract infection 
consists of nasal discharge and mild cough about 3 – 5 days.  This 
infection will progress to spread to the lower respiratory tract via 
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infected epithelial cells or cell to cell spread. Infection at the lower 
tract is marked by shortness of breath, cough, wheezing, crackles 
and nasal flaring.
 The viral infection will cause alteration of epithelial cells and 
mucosal surfaces of the respiratory tract. Earliest lesion is observed 
18 – 24 hours after the onset of the disease.  Lesions consist of 
bronchiolar cell necrosis, ciliary disruption and peribronchiolar 
infiltration with lymphocytes. Terminal bronchiolar epithelial 
cells are targets for viral infection and are damaged by direct 
viral invasion. Infants who are premature, those who suffer from 
congenital heart diseases and infection of chronic disease are 
susceptible.   Examination   may reveal wheezing and crackling 
sounds heard through stethoscope examination of the chest. Tests 
that may be done include blood gases, chest x –ray and a culture of 
a sample of nasal fluid to determine the virus causing the disease.
Antibiotics do not work against viral infections. Sometimes, no 
treatment is necessary.  Most medications do not help to treat 
bronchiolitis. To date, there is no RSV vaccine available. Anti-viral 
drug ribavirin is ineffective. Careful hand washing can prevent the 
spread of the infection
BRONCHITIS
Bronchitis is an infection of older adolescents. It is an inflammation 
of the lining of the bronchial tubes, the main airways that connect 
the trachea (windpipe) to the lungs. This delicate, mucus-producing 
lining covers and protects the respiratory system, the organs and 
tissues involved in breathing.
 With bronchitis, it may be harder for air to pass in and out of the 
lungs, the tissues become irritated, and more mucus is produced. The 
most common symptom of bronchitis is cough. When you breathe 
in (inhale), small, bristly hairs near the openings of your nostrils 
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filter out dust, pollen, and other airborne particles. Particles that 
slip through become attached to the mucus membrane, which has 
tiny, hair-like structures called cilia on its surface. But sometimes 
the pathogens get through the cilia and other defense systems in 
the respiratory tract and this can cause illness.
 Bronchitis can be acute or chronic. Most people have acute 
bronchitis at some point in their lives.  An acute medical condition 
comes on quickly and can cause severe symptoms, but it lasts only 
a short time (no longer than a few weeks). Virus causes about 90 
% of acute bronchitis whereas bacteria are fewer than 10 %. The 
viruses are rhinoviruses, adenovirus, influenza and recently the new 
emerging metapneumovirus. These viruses infect the respiratory 
tract and attack the bronchial tubes.  Acute bronchitis caused by 
non-viruses pathogens are M. pneumoniae, C. pneumoniae, B. 
pertussis and B. parapertussis..
 In acute bronchitis, these pathogens will infect the epithelium of 
the bronchi, resulting in its inflammation (swollen) and the increase 
production of the mucus. Cough, the most common symptom, is 
a natural mechanism to remove the excess mucus form the lungs. 
Other symptoms include sore throat, runny nose, nasal congestion, 
fever, fatigue and the production of sputum.
 Chronic bronchitis, a disorder in adults, on the other hand, 
can be mild to severe and is longer lasting — from several months 
to years. With chronic bronchitis, the bronchial tubes continue to 
be inflamed (red and swollen), irritated, and produce excessive 
mucus over time. The most common cause of chronic bronchitis 
is smoking. Bacterial superinfection by organisms colonizing the 
upper respiratory tract is more likely in these patients. People who 
have chronic bronchitis are more susceptible to bacterial infections 
of the airway and lungs, like pneumonia. In some people with 
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chronic bronchitis, the airway becomes permanently infected with 
bacteria. Pneumonia is more common among smokers and people 
who are exposed to secondhand smoke.
 Since the causative agent is most likely virus, antibiotics are 
not prescribed. Treatment of bronchitis is more symptomatic and 
palliative.  Expectorant and antihistamines have not been proven 
to be effective. Antiviral therapy for influenza infection is given 
early in the course of the disease. Bronchitis due to M.pneumoniae 
or C.pneumoniae can be treated with macrolide antibiotic but 
therapeutic benefit is not proven for bronchitis.
CROUP 
Croup is a condition that causes an inflammation of the upper 
airways — the voice box (larynx) and windpipe (trachea). It often 
leads to a barking cough or hoarseness, especially when a child cries.
 Most cases of croup are caused by viruses, usually parainfluenza 
virus and sometimes RSV and adenovirus. The symptoms are 
most severe in children of 6 months to 3 years old. However, older 
children are known to be infected too. Some children are more 
prone to developing croup when they get a viral upper respiratory 
infection. In most cases, the viral croup is mild and can be treated 
at home. Croup, rarely can be severe or even life- threatening.
 At first, a child may have cold symptoms, like a stuffy or runny 
nose and a fever. As the upper airway (the lining of the windpipe 
and the voice box) becomes more inflamed and swollen, the child 
may become hoarse, with a harsh, barking cough. This loud cough, 
which is characteristic of croup, often sounds like the barking of a 
seal.
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Figure 5   Croup
 If the upper airway continues to swell, it becomes even more 
difficult for a child to breathe and a high-pitched or squeaking 
noise during inhalation (called stridor) is heard. A child also might 
breathe very fast or have retractions (when the skin between the 
ribs pulls in during breathing). In the most serious cases, a child 
may appear pale or have a bluish color around the mouth due to a 
lack of oxygen. Symptoms of croup are often worse at night and 
when children are upset or crying. Besides the effects on the upper 
airway, the viruses that cause croup can cause inflammation further 
down the airway and affect the bronchi (large breathing tubes that 
connect to the windpipe).Croup symptoms generally peak 2 to 3 
days after the symptoms of the viral infection begin. Viral croup 
usually lasts 3 to 7 days.
 Croup can be detected by listening for the telltale barking cough 
and stridor. Children with croup are often diagnosed based on the 
parents description of symptoms such as a fever, runny nose, and 
congestion, and if the child has a history of croup or upper airway 
problems.  A neck x-ray is not routinely done, unless if the croup 
is severe.  An X-ray of a child with croup usually will show the top 
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of the airway narrowing to a point, which is called, “steeple sign.”
Most, though not all, cases of viral croup are mild. In severe cases, 
hospitalization is required. Steroids and epinephrine nebulizers 
decrease the airway swelling. Oxygen also might be given, and 
sometimes a child with croup will remain in the hospital overnight 
for observation.
BACTERIAL PATHOGENS
Bacterial pneumonia is a type of pneumonia caused by bacterial 
infection.  Bacterial pneumonia is more common in children 
living in developing countries. The reason is chronic malnutrition, 
overcrowding, and chronic injury to the respiratory tract epithelium 
from exposure to cooking and heating with biomass fuels without 
adequate ventilation are all rampant in developing countries. 
 Various tests that determine bacterial products in blood, 
respiratory tract secretions, and urine have been used to ascribe a 
causative role of bacteria but are positive in less than 10% of cases. 
The leading causes of bacterial pneumonia in children are caused 
by S. pneumoniae, H. influenzae and S. aureus. S. pneumonia is 
the single most common cause of pneumonia beyond the first few 
weeks of life. In countries where immunization with Hib vaccine 
is given as part of the national immunization program, including 
Malaysia, United States and many parts of Europe, the frequency 
of Hib infection, including pneumonia has markedly reduced.  S. 
aureus is an infrequent cause of community-acquired pneumonia, 
accounting for 1-5% of cases in which a bacterial cause is identified, 
but it is a recognized cause of influenza-associated community 
acquired pneumonia. The other bacteria, especially Gram-negative 
organisms, are rare causes of pneumonia in previously healthy 
children.
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Streptococcus Pneumoniae
Pneumococcal pneumoniae is a type of bacterial pneumonia that is 
specifically caused by S. pneumoniae is also called pneumococcus. 
Benjamin White in 1938 wrote that pneumococcus is altogether 
an amazing cell. Tiny in size, simple in structure, frail in make-
up, it possesses physiological functions of great variety, performs 
biochemical feats of extraordinary intricacy and, attacking man, sets 
up a stormy disease so often fatal that it must be reckoned as one of 
the foremost causes of human death. More than 60 years later, the 
pneumococcus remains a major cause of respiratory and invasive 
diseases.  The World Health Organization (WHO) estimates that 1.6 
million die every year from the disease, 0.7-1.0 million of which 
are children aged <51. S. pneumoniaeremains the leading cause of 
community-acquired pneumonia among children worldwide, with 
the highest incidence occurring in infants less than two years old 
(Rec W.E, 2007).
 Pneumococcal infection causes a variety of clinical syndrome. 
The manifestations can be broadly divided into invasive or non-
invasive pneumococcal disease. Invasive pneumococcal disease 
refers to disease in which pneumococcal enters a normally sterile 
site, such as blood, cerebrospinal fluid (CSF), pleural fluid, joint 
fluid or pericardial fluid. Non-invasive disease includes otitis media, 
sinusitis and bronchitis and is generally regarded as less serious 
compared with invasive pneumococcal disease (Randle E, 2011).
PEDIATRIC INVASIVE PNEUMOCOCCAL DISEASE 
IN A TERTIARY HOSPITAL IN MALAYSIA  
Introduction of pneumococcal conjugate vaccines has successfully 
reduced the incidence of vaccine-type invasive pneumococcal 
disease. The pneumococcal conjugate vaccine has been licensed 
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in Malaysia since March 2006. However, the vaccine has not been 
included as part of the routine vaccination program in Malaysia 
despite it being projected to prevent  around 260,000 deaths annually 
as well as having potential to mitigate the widespread antibiotic 
resistance (Sinha A, 2007). 
 There were limited publications on pneumococcal infection in 
Malaysia (Lim LH, 2007, Rohani MA, 1999). Most of the published 
data focused on serotypes isolated and antibiotics resistance pattern. 
The clinical manifestations of invasive pneumococcal disease in 
Malaysia were examined in a retrospective study by N. Othman 
et al (2010). The study was conducted in Institute of Paediatrics 
Hospital Kuala Lumpur (IPHKL), a tertiary pediatric hospital with 
500 beds which provides both primary and tertiary care.  Twenty-
five children (0-12 years old) were hospitalized from March 2002 
till Nov 2005 for invasive pneumococcal disease, who satisfied a 
clinical case definition of the disease: Isolation of S. pneumoniae 
from normally sterile specimen sites from the body (e.g.: blood, 
cerebral spinal fluid, peritoneal fluid or joint aspiration). For 
this study, the diagnosis of pneumococcal pneumonia was made 
when the clinical manifestation of pneumonia was supported by 
chest x-ray evidence if available, with isolation of S. pneumoniae 
from blood or pleura fluid (pleura: lining of the lungs). Likewise 
meningitis (infection of the lining of the brain)/sepsis (severe blood 
infection that can lead to organ failure and death)/septic arthritis 
(infection of the joints)/peritonitis (infection of the peritoneum) 
is defined as clinical features consistent with the site of infection 
and isolation of the pathogenic organism from the respective site 
or blood. 
 The study showed that two-thirds of the patients (17/24, 66.7%) 
was below 2-years-old and pneumonia represented half of these 
cases. This was consistent with other studies worldwide that showed 
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the highest incidence of this infection occurs in children below 
two years of age (Rec W. E 2007).  The study revealed sepsis and 
pneumonia were the commonest presentation, and this was followed 
by meningitis (table 2). Of the 14 patients with pneumonia, three 
developed pleural effusion or empyema (collection of fluid/pus in 
the lungs), of which only one patient required chest tube drainage. 
None of the patients required any form of surgical intervention.
 Nine patients had co-morbid factors identified; four had 
hematological conditions, three related to prematurity and the 
remaining two were associated with nephrotic syndrome (a 
nonspecific disorder in which the kidneys are damaged, causing 
them to leak large amounts of protein from the blood into the 
urine). None of the patient received any types of pneumococcal 
vaccine before the current admission. Only three patients received 
antibiotics within 30 days of admission. 
Table 2  Manifestations of invasive pneumococcal disease
Diagnosis Number of patients (%)
Sepsis 14 (50)
Pneumonia 14 (50)
Meningitis 10 (41.7)
Cellulitis 3(12.5)
Peritonitis 2 (8.3)
Septic arthritis 2 (8.3)
Acute glomerulonephritis 1 (4.2)
 More than half of the patients required prolonged hospitalization 
(stayed more than two weeks) and ventilation (duration1-24 days). 
Seven of these children, who were ventilated and had prolonged 
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hospitalization, also had pneumonia. There were two mortalities, 
both were infants (age less than one year) and meningitis was 
the cause of death. The high percentage of mortality (8.3%) and 
patients requiring intensive (54.2%) support could be explained 
by the study centre being a tertiary referral centre which provides 
support for referral cases from the whole country.  The mortality 
data presented concurs with other studies on invasive pneumococcal 
disease in other regions of the world, ranging from 3.2% to 23.5% 
and meningitis is the cause of fatality in most of the studies (Bravo 
L., 2009, Katherine L O’ Brien, 2009).
 In our study, atypical presentations of invasive pneumococcal 
disease were encountered. Three patients, all premature newborns 
had invasive pneumococcal disease within the first 24 hours of life 
and all survived. They presented with manifestations of meningitis, 
pneumonia and pneumonia with sepsis respectively. From literature 
search, S. pneumoniae is a rare cause of invasive pneumococcal 
disease in newborns (Westh H, L Skibsted et al. 1990; Geelan S.L, 
1990).  S. pneumoniae is not a normal vaginal flora. The newborns 
acquire the infection through maternal bacteremia (S. pneumoniae 
in blood), transplacental, ascending infection from genital tracts, 
while passing through birth channel or through the respiratory tract 
at postpartum period.  The clinical course strongly resembles early 
onset group B streptococcal disease. However, in comparison with 
group B streptococcal, it has higher mortality and morbidity. In view 
of the high invasion rate and potential disastrous outcome, treatment 
of the asymptomatic newborns colonized by S. pneumoniae has 
been recommended.
 The second atypical presentation reported in our series was 
a healthy infant presenting as purpura fulminans (I. h. Intan, 
2009). The majority of cases of purpura fulminans are associated 
with Neisseria meningitidis sepsis (Purpura fulminans: a rare 
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life threatening skin disorder with extensive areas of blueblack 
hemorrhagic necrosis associated with sepsis or serious infection). 
However, other bacteria, including S. pneumoniae, can also be the 
cause and in most cases it occurs in asplenic (condition without a 
spleen) or immunocompromised adults rather than in children.  To 
our knowledge, only five cases of pneumococcal purpura fulminans 
in healthy children have previously been reported (Noguera 
A, 2004).The mortality rate in this condition has recently been 
significantly reduced, largely because of aggressive replacement 
of platelets and coagulation factors.
 Post-infectious acute glomerulonephritis (AGN) is a common 
disease in children and classically caused by nephritogenic strain 
of group A B-hemolytic Streptococcus (GABHS ).Affected children 
with AGN present with red urine described as smoky coca-cola like 
colour (hematuria), puffy eyelids in the morning and may progress 
to swelling of both limbs.  Most of the time the swelling is not 
marked and associated with reduced urine output and hypertension. 
Glomerulonephritis following infections with other microbial 
agents, such as S.pneumoniae has rarely been described.  To date 
8 cases have been reported over the past 3-4 decades; 5 in children 
and 3 in adults (Chanceller Lech A, 2010, Phillips J, 2005). In these 
reported cases, pneumococcal serotypes 5, 6B, 7, 9, 14, 15 and17F 
have been described as nephritogenic strains. Similar to our case, 
almost all reported cases have reported pneumococcal bacteremia 
suggesting that the rarity of pneumococcal glomerulonephritis could 
be attributed to the invasive form of pneumococcal infection itself. 
Our patient had an uneventful acute nephritis and a stable blood 
pressure throughout hospitalization (Intan HI, 2007).
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EMERGENCE OF PENICILLIN-RESISTANT 
STREPTOCOCCUS PNEUMONIAE (PRSP)
A case of a 19-month old with PRSP with severe pneumonia and 
bilateral pleural effusion, prompted us to embark on a literature 
search on this growing problem (MZA Hamid et al, 2008).
 Although S. pneumoniae was once considered to be routinely 
susceptible to penicillin, resistance started to develop in the 1960s. 
Penicillin kills the bacteria by binding to the protein on the cell wall 
and reducing the peptide chain production, which further weakens 
the cell wall.  Minimal inhibitory concentration (MIC) is a scale 
that measures the resistance of the bacteria to a particular antibiotic. 
Resistant strains are categorized into susceptible if MIC is less than 
0.06 ug/ml, of intermediate if MIC is 0.1 t0 1.0 ug/ml and resistant 
if MIC is greater than 2.0 ug/ml. 
Figure 6   Prevalence of Penicillin Nonsusceptible and Resistant 
Isolates of S. pneumoniae
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 Heathet PT et al (2002) found that the prevalence across Europe 
in a decreasing order was as follows: Spain (51.0%) followed 
by Hungary (57.8%), and lowest in more developed countries 
namely Germany (1%) and Netherlands (2%). Prevalence was 
also noted to be significantly higher in other parts of the world, 
such as in South Africa which reported 62.2% cases of penicillin-
resistant community-acquired pneumonia and approximately 
70% in population studied in South Korea.  The Asian Network 
for Surveillance of Resistant Pathogens (ANSORP) documented 
that in Malaysia there was an increase in incidence of nearly 
four-folds (10% in 1996 and 43% in 2003) of penicillin –resistant 
pneumococcal pneumonia, however the cases reported in our 
country might represent only the small fractions of the actual 
problem (Song JH, 2004).
 Identif iable risk factors associated with PRSP include 
previous use of antibiotics, children from countries with high 
prevalence of antibiotic resistance, patients on private medical 
coverage, immunodeficiency patients and those not responding to 
conventional antibiotic therapy (Deeks SL, 1999).
 Due to the complexity of the PRSP, it leads to believe that any 
pneumococcal pneumonia warrants alternative and most of the time 
expensive antibiotics. However evidences have suggested penicillin 
or earlier generation cephalosporin group antibiotics appeared to 
be adequate in treating susceptible or intermediate resistant SP. 
Clinicians should reserve the use of third-generation cephalosporin 
and to certain extent vancomycin, only to the cases suspected to be 
pneumococcal resistance (MIC > 2.0 µg/ml) (Heath PT).  It also 
showed that PRSP were no less virulent when compared to other 
normally susceptible strains.  Mortality rate due to PRSP strains 
and non-PRSP strains showed no significant difference as reported 
by Deeks et al (1999).
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The emergence of these PRSP strains has made the management 
of these cases more difficult. This highlights the importance of 
possible prevention by vaccination coverage in these vulnerable 
children.  Nonetheless, at present it is imperative for all clinicians 
to be aware of PRSP pneumonia and how best to identify and 
manage it effectively.
Staphylocococus aureus
Staphylococcus was first identified in Aberdeen, Scotland (1880) by 
the surgeon Sir Alexander Ogston  from a surgical abscess in a knee 
joint. This name was later appended to S.  aureus by Rosenbach who 
was credited by the official system of nomenclature at the time. It is 
estimated that 20% of the human population are long-term carriers 
of S. aureus, which can be found as part of the normal skin flora and 
in anterior nares of the nasal passages. S. aureus is a successful 
pathogen due to a combination of nasal carriage and its bacterial 
immuno-evasive strategies (Sarah S. Long, 1997)
 Most of the time, the organism does not cause any harm; 
however, sometimes it causes infections including pneumonia. Until 
recently, staphylococcal pneumonia was considered an uncommon 
community-acquired pneumonia, accounting for 1%–5% of all 
community-acquired pneumonia  cases and occurring primarily 
in patients with influenza. In addition, S. aureus was recognized 
as an important but infrequent cause of nosocomial pneumonia. 
However, in the past 2 decades, there have been important changes 
in S. aureus pulmonary infection. First, methicillin-resistant 
S.aureus (MRSA) emerged as a nosocomial pathogen in the early 
1960’s, soon after the introduction of methicillin. Since then, it 
has become the main cause of nosocomial infections.  It is now 
present in the hospitals of most countries (Ayliffe G, 1997;  Wenze 
RP 1991). All MRSA strains were once susceptible to vancomycin. 
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However, reduced susceptibility to MRSA to vancomycin, known 
as vancomycin -intermediate S.aureus (VISA) was first identified 
in Japan in1996 and has since been found in hospitals elsewhere 
in Asia as well as other parts of the world (Appelbaum PC,2007). 
These bacterial strains present a thickening of the cell wall, which 
is believed to reduce the ability of vancomycin to diffuse into 
the division septum of the cell required for effective vancomycin 
treatment. In 2002, the strain became completely resistant to 
vancomycin; labeled as vancomycin-resistant S.aureus (VRSA). It 
was isolated from the catheter tip of a diabetic, renal dialysis patient 
in Michigan. From 2002 to 2010, ten additional VRSA isolates 
were reported, eight from the United States, one from Iran, and 
one from India. The appearance of these strains make treatment of 
infected patients much more difficult, especially in situations where 
an effective treatment for an infection is needed urgently, before 
detailed resistance profiles can be obtained. 
 Until recently, most of the MRSA strains causing health 
care–associated pneumonia (HAP), were labeled hospital-acquired 
MRSA and contained the staphylococcal cassette chromosome 
(SCC) mec types I–III (Kaplan SL, 2005).  Recently, however, a new 
variant of MRSA has emerged as a pulmonary pathogen. This new 
variant of S. aureus that causes pneumonia is community-acquired 
MRSA (CA-MRSA), containing SCCmec type IV-V.   Table 3 
differentiates health-care associated MRSA from community 
associated MRSA.
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Nasal carriage of Staphylococcus aureus Among 
Healthy Adults
In humans, S. aureus colonization is mainly found in the anterior 
nares (Lowy FD, 1998).  Nasal carriage of S. aureus is a potential 
source of infection and colonization often precedes infection. In 
general, nasal carrier rates among hospital personnel and patients 
(60-70%) are much higher as compared to those among community 
carriers (30-50%).Data on the carriage rate and antibiotic sensitivity 
pattern of S.aureus strains prevalent in the community are not 
available for many developing countries including Malaysia. 
Furthermore, most studies on nasal carriers on S.aureus in Malaysia 
were carried out in hospital and outpatient settings, involving 
patients and hospital staff. 
 We conducted a cross-sectional study involving 346 healthy 
adults over 18 years of age. They were both preclinical and health 
sciences students, staff, and visitors at the preclinical block of the 
Faculty of Medicine and Health Sciences, Universiti Putra Malaysia. 
Individuals who were recently hospitalized were excluded and most 
stayed on campus. Nasal swabs were examined for the presence of 
S. aureus. Epidemiological information concerning risk factors for 
nasal carriage was also obtained. Antibiotic susceptibility testing 
was performed using the disk diffusion method according to the 
National Committee for Clinical Laboratory Standards guidelines. 
MRSA strains isolated were further subjected to pulse-field gel 
electrophoresis analysis.
 The study showed a prevalence rate of 23.4% (81/346) of S. 
aureus nasal carriage in the study sampled. From 346 nasal swabs 
collected, only 1 MRSA isolate was identified while 80 persons 
were found to be nasal carriers for methicillin sensitive S. aureus 
(MSSA). The MRSA strain (different from the hospital strain) was 
isolated from a healthy individual who had noprevious history of 
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hospitalization and antibiotic intake prior to the sampling. However, 
history of contact with hospitalized persons was not available.  In 
this study, the low prevalence of MRSA nasal carriage in a healthy 
population appears to contrast with the diverse dissemination of 
methicillin-sensitive S. aureus (MSSA). MRSA strains are known 
to exhibit lower adherence to the nasal mucosa, rendering isolation 
of these strains from colonized nares seemingly more difficult.  
 Consistent with previous reports, we found that smoking, 
particularly among ex-smokers, was associated with S. aureus 
colonization. Smoking is known to alter the respiratory mucosal 
surface, facilitating the binding of potential pathogens, particularly 
S.pneumoniaeand H. influenzae, and to a lesser extent S. aureus. 
This leads to an increased risk of airway colonization and 
development of pneumonia (El Ahmer OR, 1999). Raman et al also 
found that pneumococcal adherence in some ex-smokers remained 
high for up to 3 years after smoking cessation (Raman AS, 1983). 
However, the etiological basis of this observation is unknown. Our 
data also indicated that oral contraceptive users are at increased 
risk of harboring S. aureus nasal carriage. As there is a scarcity 
of data on this specific interaction, further studies are required to 
determine the actual relationship of oral contraceptives to S. aureus 
nasal carriage.  We first reported the appearance of CA-MRSA in 
Malaysia and concluded that MRSA nasal colonization was found 
to be low outside of the health care environment. Smokers and oral 
contraceptive users have high nasal carrier rates.
Methicillin-Resistant Staphylococcus aureus (MRSA) 
Nosocomial Infection in Malaysia
As there was an unusual increase in the number nosocomial cases 
during the surveillance audit in Institute Pediatrics, Hospital Kuala 
Lumpur in 1998, we studied retrospectively the prevalence of 
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MRSA nosocomial infection in the pediatric wards (Norlijah O, 
2004). In our study, we also identified the susceptible groups of 
patients, ascertain the associated risk factors and further determine 
the antibiotic susceptibility pattern of MRSA isolates of these 
patients during a six-month period study in that year. The definition 
of nosocomial infection followed the Center of Disease Control 
(CDC) criteria; is defined as those infections that occur or originate 
in a hospital or hospital-like setting. In our study it was   considered 
a nosocomial infection if positive MRSA culture was obtained from 
specimens and appropriate therapy instituted and deemed as an 
infection by the physician in-charge. Colonization was excluded.  
 The nosocomial rate was found as 0.93% (206/20893); MRSA 
was second to Escherichia coli. A total of 25 cases had MRSA 
infection, with a median age of 36 months, ranging between day 
4 of life to 14 years of age. Figure 7 illustrates the distribution of 
MRSA nosocomial infection in the respective wards; the neonatal 
ward had the highest number of cases as compared to the other 
areas in the hospital. 
Figure 7  Number of cases of MRSA nosocomial infection in the 
respective wards
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 The neonates are most susceptible as their immunity has hardly 
developed, have more complications, exposed to various modalities 
of invasive therapies and tend to stay in the hospital longer (Val 
G Hemming, 1970). There were two distinct groups identified; 
those aged less than 3 months and those aged 3 months and older. 
Pneumonia was the presenting feature in the older age group while 
the younger ones manifested as septicemia. None of the patients 
presented with urinary tract infection or meningitis. Diagnosis of 
any form of meningitis is important, as prognosis is dismal and 
associated with high mortality. Lumbar puncture could not be 
obtained as permission was not granted from parents/guardians in 
most cases and occasionally patients were too ill to be subjected 
to the procedure.
 We also found that more than one predisposing factor was 
present in each case of infection, as shown in Table 4. Prolonged 
hospitalization and co-morbid conditions were predominantly 
associated with increased MRSA nosomial infection in the older 
group. All isolates were sensitive to vancomycin, fusidic acid and 
rifampicin, and resistant to erythromycin and tetracycline. A high 
percentage of the isolates were resistant to sulphamethoxazole-
trimethoprim (88%), chloramphenicol (80%), gentamacin (64%) 
and amikacin (50%). One isolate was resistant to ciprofloxacin. 
Vancomycin was the antibiotic of choice while a combination of 
fusidic acid with rifampicin was administered to one patient.
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 To conclude, it should be stressed that MRSA prevention and 
control should consist of isolation of patients with MRSA especially 
in intensive-care units, strict enforcement of hand-washing and other 
aseptic techniques, use of disposable equipment and products, and 
continuing education of medical personnel on the communicability 
of MRSA (Mulligan M ,1993). Early identification of patients at 
risk, prompt discharge of patients, and preventing dissemination 
while performing invasive procedures achieve reduction of MRSA 
infection/colonization in the hospital.
Predominance and Emergence of Clones of Hospital-
Acquired Methicillin-Resistant Staphylococcusaureus 
in Malaysia
As mentioned earlier, MRSA causes both health care-associated 
(HA) and community-acquired (CA) infections. Modern MRSA 
has evolved from several successful clonal lineages of methicillin-
susceptible S. aureus strains via acquisition of a mobile genetic 
element called staphylococcal cassette chromosome mec(SCCmec). 
This element contains the mecAgene, which encodes penicillin-
binding protein 2 (PBP2) with significantly reduced affinity for 
B-lactams (Robinson, D, 2003)
 Increased emergence of multidrug resistance among MRSA 
strains has become a major concern in the hospital environment, as 
it invokes a tremendous financial burden and enhanced morbidity 
and mortality due to hard-to-treat systemic infections.  MRSA was 
introduced into Malaysia in the early 1970s , (Lim, V. K 1987), and 
a review of the records of the microbiology laboratories of all state 
hospitals in Malaysia showed that the proportion of MRSA isolates 
from S. aureus-infected individuals had been approximately 21% 
throughout the last few years. 
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Phenotypic MRSA typing methods are not suited for detailed 
epidemiological surveillance; in tracing the nosocomial sources 
and transmission routes of the bacterial pathogen.  Several superior 
molecular typing methods can be used for supporting infection 
control and these include:
•	 Pulsed-field gel electrophoresis- the current gold standard 
method
•	 Multilocus sequence typing (MLST) -has recently been proven 
to be the best for long term global epidemiological and bacterial 
population genetics studies
•	 Spa typing: Similar sequence typing  (a combination of alleles 
from the seven loci forms a sequence type) are grouped into 
clonal complexes
•	 Virulence gene profiling
 Molecular typing data on HA MRSA isolates in Malaysia are 
sparse in comparison with those on strains deriving from Europe, 
the United States, or Japan. Pilot data hinted at the predominance of 
a single MRSA genotype in Malaysia. This is similar to the situation 
in many other Asian countries (Ko, K. S. 2005; Nor Shamsudin, 
M. 2008)
 Hospital Kuala Lumpur (HKL) is the largest government 
tertiary referral hospital with 81 wards and 2502 beds. Each year 
at least 1 million people (3.8% of the total Malaysian population) 
are referred and treated here from all states in Malaysia. The 
epidemiology of any nosocomial infection in this hospital will 
most likely reflect the nation’s epidemiology as it is a major referral 
hospital. It also records an annual MRSA prevalence of over 40%.
Many of these MRSA strains are multidrug resistant. As additional 
epidemiological studies were clearly warranted in order to increase 
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the insight into the dynamics of MRSA epidemiology in Malaysia, 
it prompted us to embark on a study to characterize the current 
Malaysian MRSA isolates and further determine their molecular 
epidemiology by molecular methods as described above. 
 The clinical isolates collected were from October 2007 to 
September 2008. Out of a total number of 1,887 MRSA strains, 
a random selection of 389 strains was investigated in molecular 
detail. All isolates previously identified to the species labelled bythe 
hospital laboratory were reconfirmed in the microbiology laboratory 
at Universiti Putra Malaysia by standard methods such as Gram 
staining, catalase testing, tube coagulation, mannitol testing, and 
MRSA screen latex agglutination testing (Denka Seiken Co., Ltd., 
Tokyo, Japan). Isolates were confirmed as MRSA by oxacillin and 
cefoxitin susceptibility testing according to the CLSI guidelines. All 
isolates were also reevaluated for the presence of the mecAgene by 
PCR. Confirmed MRSA isolates were then stored at _80°C in Luria-
Bertani broth supplemented with 20% glycerol and subsequently 
subjected to pulse-field electrophoresis, MLST, spa typing and 
virulence gene profiling
 The majority affected were adults. The median age of patients 
in the study was 47.8years, and the age range was from 4 days to 88 
years. In agreement with earlier reports, the prevalence of MRSA in 
this study did not vary by gender (Kairam, 2009). When data were 
stratified according to the three major ethnic groups in Malaysia, 
the prevalence of MRSA infection among Indians was found to be 
significantly elevated.  A similar observation was reported for CA 
MRSA in African-American children (Sattler, C. A, 2002).
 The highest rate of MRSA, as reported from our general 
medicine ward, is in the dermatology ward, with a high rate of 
skin and soft-tissue infection. The short hospital stay and adequate 
antibiotic therapy in otherwise healthy patients in the maternity 
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ward explain the low prevalence in that ward (Udo E. E, 2006). 
The frequencies of MRSA isolates obtained from different type of 
specimens are summarized in Figure 8. Respiratory samples were 
second to purulent specimen from skin and soft tissues; this finding 
is expected as these are common commensal sites for this organism. 
Figure 8  Number of specimen from several sites completed positive 
for MRSA
 Several international epidemiological investigations 
demonstrated that most hospital-acquired MRSA infections are 
caused by a relatively small number of epidemic MRSA clones 
spread worldwide. The most frequently encountered clones are the 
Iberian (ST-247-IA), Brazilian/Hungarian (ST-239-III), Berlin (ST-
45-IV), New York/Japan (ST-5-II), pediatric (ST-5-IV), EMRSA-15 
(ST-22-IV), and EMRSA-16 (ST-36-II) clones (33). We here showed 
the predominant clone in Malaysia was ST-239 (CC8), spa type 
t037, and possessed SCCmec type III/IIIA . This clone is also 
dominant in most other Asian countries except South Korea and 
Japan (Ko, K. S, 2005). 
 We present the first cases of infection by ST-22, SCCmec 
type IVh, with three different spa types (t932, t3213, and t4184)
35 ❘❘❚ 
Norlijah Othman
in Asia. These strains were mainly isolated from blood (66.6%) 
or skin and soft-tissue infection (33.3%). SCCmecIVh, present in 
a recently described specific subtype ofEMRSA-15 (ST-22), was 
reported for the first time in Portugalbut shortly after from places 
as distant as Sweden (Berglund, C., 2009) and lately from Spain 
(Vindel, A., 2009).The SCCmecIV element is small in comparison 
to elements such as SCCmec type III; the small size enables easier 
spread among S. aureus strains. As a possible consequence of its 
enhanced mobility, it is also more variable than other SCCmec types. 
The detection of ST-22(which is one of the predominant MRSA 
clones in Europe, Australia, New Zealand, in Singapore and later 
in Malaysia) strengthens the case for the epidemic nature of this 
clone and also suggests that it may easily spread to other Southeast 
Asian countries.
 A limited number of community-acquired MRSA strains 
were also detected. These included ST-188/t189 (2.1%), ST-1/t127 
(2.3%), and ST-7/t091 (1%). Panton-Valentinleukocidin (PVL) was 
detected in all ST-1 and ST-188 strains. The majority of the isolates 
carried agr I, except that ST-1 strains were agrIII positive. 
 The results revealed the predominance of ST-239-SCCmec 
III/IIIA and the penetration of ST-22 with different virulence 
gene profiles. In addition, minor groups of community-acquired 
MRSA strains detected in the current study indicate the abilityof 
such strains to settle in the hospital environment. The emergence 
in Malaysia of novel clones of known epidemic and pathogenic 
potential should be taken seriously.
Mycoplasma pneumoniae
Mycoplasma pneumoniae is a very small bacterium in the class 
Mollicutes. M pneumoniae is the smallest free-living organism 
capable of self-replication smaller than some viruses; it causes 
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the disease mycoplasma pneumonia, a form of atypical bacterial 
pneumonia. This species lacks a cell wall, like all Mollicutes. 
Instead, it has a cell membrane that incorporates sterol compounds, 
similar to eukaryotic cells.  It obtains these sterols from the host 
serum, allowing it to retain a simple structure. Lacking a cell wall, 
these organisms are resistant to the effects of penicillins and other 
beta-lactam antibiotics, which act by disrupting the bacterial cell 
wall (Jawetz, 1995).
 In 1938, Reimann described the first cases of mycoplasmal 
pneumonia in man and coined the term “primary atypical 
pneumonia” after observing 7 patients in Philadelphia with 
marked constitutional symptoms, involving the respiratory tract, 
and runs a protracted course with gradual resolution. Peterson 
discovered the phenomenon of cold agglutinin in 1943; high titers 
of cold agglutinins in patients with primary atypical pneumonia 
were discovered accidentally. In 1944, Eaton was credited with 
discovering a specific agent, coined Eaton’s agent, as the principal 
cause of primary atypical pneumonia.First thought to be a virus, 
Eaton’s agent was proved to be a Mycoplasma species in 1961.
 M. pneumoniae is a common cause of community-acquired 
pneumonia.  It can cause upper or lower respiratory infections, or 
both. M.pneumoniaewas first isolated in cattle with pleuropneumonia 
in 1898. Once considered to occur primarily among adolescents and 
young adults, M. pneumoniae is increasingly recognized as a cause 
of lower respiratory tract disease in young children. 
 Although LRIs due to M. pneumoniae classically result in 
mild and self-limited disease, more severe illness is known to 
occur as illustrated in our case of a 5-year-old boy who presented 
with a short history of fever, cough and respiratory distress (N 
Othman, 2005). During this episode, the patient sought treatment 
from a general practitioner twice and was prescribed antipyretic 
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and antibiotics but the illness did not improve. His chest X-ray 
revealed large right pleural effusion compatible with the clinical 
findings on examination. An immediate chest drainage was inserted 
and purulent discharge with large amount of pus cells were shown 
microscopically. The diagnosis of M. pneumoniae infection in this 
case was made on clinical and serologic grounds as serologically 
there was  a four –fold rise in M. pneumoniaeIgMtitre (a single 
initial titre of 1:5120 followed by four-fold rise in antibody titre 
to 1:>20,480).  The fever took 15 days to settle. The empyema 
required drainage for more than 2 weeks and the infection resolved 
with a course of six weeks of antibiotics. This case highlights the 
importance of considering M. pneumoniae infection as a cause of 
community-acquired pneumonia especially in children over 5-years 
old, of whatever the severity may be, and of starting the appropriate 
antibiotic therapy. 
 M. pneumoniae infection was also previously thought to cause 
only benign respiratory disease affecting the upper respiratory tract 
more than lower. Further reports showed it could also cause severe 
disease not limited to the respiratory tract. Abnormalities in almost 
every organ system have been associated with M. pneumoniae 
infection including neurologic, dermatologic, gastrointestinal, 
hematologic, cardiovascular, musculoskeletal and renal.
 Clinical detection of M. pneumoniae is problematic given both 
the absence of any distinctive presenting clinical manifestations, 
routine laboratory parameters, or radiographic findings and lack of 
standardized, rapid diagnostic test.  Serologic testing is commonly 
used to diagnose M. pneumoniae but is not useful for acute 
management because a convalescent serum is required. Culture is 
time consuming and expensive, while polymerase chain reaction, 
although potentially allowing a rapid diagnosis, is costly and neither 
culture nor PCR are available in most centres (Honda J, 2000).
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Mycoplasma pneumoniae Infections in Australian 
Children
The clinical features of M. pneumoniae are well elucidated in 
other continents such as America, Europe and Asia. As there was 
no data on M.pneumoniae infections in Australia then, the clinical 
features in children were examined in a restrospective study by N 
Othman et al (2005). We observed 76 children, who were either 
seen as out-patients or hospitalized from June 1997 to August 2002. 
The included cases satisfied a case definition of M. pneumoniae: a 
serological diagnosis of a four-fold rise in complement fixation titre 
(CFT) or a single CFT of 1:64 or greater, associated with clinical 
manifestations compatible with M. pneumoniae infection. 
 There were 42 (55.3%) boys and34 (44.7%) girls. The age 
distribution is shown in Figure 9. The incidence of M. pneumoniae 
pneumonia was still the highest, nevertheless, among the 
schoolchildren aged 5–9 years, with a second peak in children 1–5 
years of age. Infants were not completely spared from infection, but 
we found, like others, that infants less than 1 year old were rarely 
affected. M.pneumoniae pneumonia was traditionally thought to 
occur mainly in school-aged children and to be rare in children 
under 5 years of age. However, from the 1970s onwards, studies 
indicated that M. pneumoniae infection was not rare in children 
less than 5 years old (Ponka A, 1983; Bosnak M, 2002). Our 
results are consistent with other studies, which emphasized that 
M. pneumoniae should be kept in mind as a cause of community-
acquired pneumonia in children less than 5-years-old.
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Figure 9  Age distribution of patients admitted with Mycoplasma 
pneumoniaeinfection.
 This infection was found to occur throughout the year, with 4-6 
cases seen in most months as seen in other continents as Europe and 
America.  A peak was observed from June to July with a slightly 
less than a third (23/76,30.1%) of the total cases were seen during 
that period of the year. 
 The clinical picture observed in our study, did not differ greatly 
from those described in other studies (Clyde AW, 1993; Cherry 
JD, 2004). Fifteen children had extra respiratory manifestations, 
majority (11/76, 0.14% ) presented with rash, of which two had 
erythema multiforme (skin disorder : may be severe and has 
classical “target lesionappearance, with a pink-red ring around 
a pale center)and Kawasaki respectively (autoimmune disease 
affecting the medium-sized blood vessels throughout the body 
become inflamed, untreated leads to coronary artery aneurysm).
 Comparing children infected with M.pneumoniaeover 5 years 
old versus ≤5yearsdemonstrates that the younger children were 
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more likely to have coryza,diarrhoea, vomiting, rapid breathing 
and recession.
  The proportion of younger children to be hospitalized was 
also slightly more than the older children.  Five patients had mixed 
viral/bacterial infections in this series. In contrast to a previous 
large study, co-infections of M. pneumoniae with other organisms 
were verycommon, but did not appear to be associated with more 
severe manifestations.  On laboratory assessment, the presence 
of thrombocytosis (defined as platelet count of more than 400 x 
10 9 /L) in 40% of the cases has not previously been reported in 
children. Chest-x-ray findings were none-specific.  All patients were 
discharged alive with no sequelae except the child with meningo-
encephalitis (brain infection). 
 In conclusion, our data underlines the role of M. pneumoniae 
in children with community-acquired pneumonia, even in children 
aged less than 5 years old. We found that children under 5 years old 
were more likely to present with non-respiratory symptoms such 
as diarrhea and vomiting, as well as with coryza and recession and 
they were as expected more likely to be hospitalized as compared 
to the older children.
Seropositive versus Seronegative Children with 
Mycoplasma pneumoniae Infection in Children-Could 
We Predict the Infection in Terms of the Clinical 
Parameters? 
Distinguishing acute M.pneumoniae infection has clinical 
relevancebecause rapid diagnostic tools are not readily available 
and, more importantly, M. pneumoniae does not respond to the usual 
first-line antibiotics. The decision to commence macrolide therapy 
for mycoplasma infection is based on in vitro sensitivity of the 
organism, but this test is not available in most centers. The present 
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study attempts to predict M. pneumoniae infection in children in 
terms of the clinical parameters (clinical features, laboratory, and 
chest-x-ray findings) by comparing those with positive versus 
negative serology results (Norlijah Othman, 2008). We assumed 
that seropositive children had true M. pneumoniae infection and that 
seronegative children were not infected. Because the majority of 
patients had a single titer without convalescent serum available and 
molecular diagnostic test such as PCR of sputum was not performed 
for any patients, those in the seropositive group may not represent 
a definite infection and vice versa. Nonetheless, a seronegative 
group of symptomatic children is a more realistic control group 
than asymptomatic patients.
 The diagnosis of M. pneumoniae infection was based on 
serological evidence obtained by a complement fixation test. A 
single antibody titre of 64 or more or a four-fold or greater rise 
in antibody titre between acute and convalescent serum taken 1 
to 2 weeks apart was considered seropositive for M. pneumoniae 
infection. On the other hand, a patient with an antibody titre of less 
than 64 or with paired sera showing less than a four-fold rise in titre 
was considered seronegative.
 A total of 151 children were included for analysis in this 
retrospective study. Seventy-six children were seropositive for M. 
pneumoniae and the remaining 75 were seronegative. Children 
with positive M. pneumoniae serology were slightly younger (mean 
age 6.3 ± 3.5 versus 6.6 ± 4.0 years) and males were slightly over-
presented in both groups. The mean temperature on admission 
was almost identical in both groups: 37.8º C versus 37.7ºC in 
seropositive and seronegative patients respectively. There was no 
difference in either group of patients in terms of underlying diseases 
and positive history of cough among family members. The study 
showed that children infected with M. pneumoniae presenting with 
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pneumonia were more likely to have a history of fever >6 days 
duration, as shown in Table 5. Similarly, other studies reported that 
patients with M. pneumoniae pneumonia had a longer duration of 
fever compared to those without the infection (Fischer JE, 2002; 
Chan P, 2001). Asking a simple question regarding the duration 
of fever can identify patients with a higher risk of M. pneumoniae 
infection.
Table 5 Distinguishing clinical parameters between seropositive versus 
seronegative Mycoplasma group
M.pneumoniae 
seropositive
M.pneumoniae
seronegative P
n=76 % n=75 %
Age > 3 years 59 77.6 63 84 0.321
Family members 
with cough
15 17.1 6 8 0.230
Duration of fever 
>6 days
37 69.8 16 30.2 0.0004*
Fever 63 82.9 53 72.6 0.130
Cough 70 92.1 67 89.3 0.557
Running nose 26 34.2 30 40.5 0.423
Wheeze 27 35.5 35 46.6 0.164
Headache 9 11.8 9 12.0 0.976
Crackles 55 73.3 41 54.7 0.0172*
Bronchial 
breathing
7 9.3 4 5.3 0.347
Pneumonia# 64 84.2 36 48.0 <0.0001*
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Asthma# 9 11.8 22 29.3 0.0078*
Upper respiratory 
tract infection#
1 1.3 9 12.0 0.0083*
Hemoglobin <10 
g/L 
5 7.1 1 1.5 0.102
Thrombocytosis 
>400 x 109/L
29 41.4 15 23.1 0.023*
Consolidation 56◊ 80 35¥ 57.3 0.0001*
Peribronchial 
thickening
20◊ 37.7 33¥ 54.1 0.0024*
*P< 0.05
# Final diagnosis on discharge
◊M. pneumoniae seropositive n= 70
¥ M. pneumoniaeseronegative n= 61
 Seropositive children were also significantly more likely 
to have a discharge diagnosis of pneumonia than seronegative 
children while seronegative children were more likely to have 
a diagnosis of upper respiratory tract infection. Although most 
infections with M. pneumoniae are related to upper respiratory tract 
infection, and pneumonia develops in only 3% of infected persons 
(Clyde AW, 1993), the present study showed that M. pneumoniae 
infection was more likely to be established in cases diagnosed 
as pneumonia. In contrast, upper respiratory tract infection was 
more likely to be associated with the seronegative group. These 
findings supported the fact that upper respiratory tract infection is 
attributed to viruses more frequently than M. pneumoniae infection. 
Furthermore, it highlights that M. pneumoniae plays an important 
role in community-acquired pneumonia in children.
 In terms of symptoms, no difference was found in the 
proportion of patients who had fever, cough, wheezing, headache, 
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breathlessness or coryzal symptoms although there was a trend 
for seropositive children to report lethargy. Crackles on physical 
examination were found by us to be more likely in M. pneumoniae 
pneumonia, although no specific clinical features were identified 
in previous studies in children (Fischer JE, 2002; Chan PW, 2001). 
 Chest films are useful diagnostic tools for the detection 
of pneumonia in children. The present study suggested that 
consolidation was associated with M. pneumoniae pneumonia, 
while peribronchial thickening was more prevalent in those without 
M. pneumoniae infection. Attempts to differentiate the type of 
pneumonia from ‘characteristic’ radiographic changes are likely 
to be unsuccessful because radiological interpretation is subject to 
inter- and intra-observer variability (Davies HD, 1996). 
 As a conclusion, identifying children with M. pneumoniae 
infection is not always easy. The differences observed between the 
present seropositive and seronegative children showed that there 
were real differences between the groups as a whole.The present 
study indicates that serology for M. pneumoniaeis more likely 
to be positive in children with pneumonia rather than in upper 
respiratory tract infection. In addition, duration of fever of more 
than 6 days, finding of crackles on auscultation and radiographic 
lung consolidation are more likely to be found in M. pneumoniae 
infection. These clinical parameters should be considered when 
deciding if antibiotics are needed and if so whether a macrolide, 
the appropriate therapy for Mycoplasma infection is indicated. 
VIRAL PATHOGENS
Viruses are the most common cause of lower respiratory tract 
disease in infants and young children, and are a major public health 
problem in this age group.  Viral infection of the lower respiratory 
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tract most often is benign; however occasionally it can be fatal. 
Each year approximately 3% of all children less than 1 year of age 
need to be admitted to the hospital with moderate or severe viral 
lower respiratory tract infection. Costs attributable to viral lower 
respiratory tract infections in both outpatient and inpatient settings 
are an important burden on national healthcare budgets.
 For optimum treatment is given at the onset of the disease, it is 
also important to differentiate viral and bacterial infection so that 
optimum treatment is given at the onset of the disease. It is also 
important that no antibiotics be prescribed if it is a viral infection 
to prevent resistance of antibiotics by the organism. To achieve 
this, a rapid identification of viral infection is important. This 
will reduce overall reduction of antibiotics use, the need of other 
diagnostic tests can be reduced and isolation of infected patients 
and subsequently help control any infection during hospital stay or 
nosocomial transmission (1).
There two types of LRI viruses:  
A. Well established viruses
B. Newly discovered viruses / unknowns
a)  Well-Established Viruses
These are known to cause seasonal infections. Up until two 
decades ago only influenza, respiratory syncythial virus (RSV), 
parainfluenza virus, rhinoviruses, enterovirus and adenovirus were 
the established causes.  
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Figure 10a  Multiplex PCR for detection of respiratory infections
Figure 10b  Detection of HBOV using PCR
 A summary of the common diseases and seasonal outbreaks 
of LRI of these viral pathogens is given in the following Table 6. 
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b) New Discovered Viruses /Unknowns
Rapid and state of the art diagnostic tools have made it possible 
to identify new viruses in the   lower respiratory tract. Some of 
the pathogens identified were previously undiagnosed infection 
(Hustedt, 1993). Investigations were hindered as it was difficult to 
collect appropriate lower respiratory specimens (Garbino, 2004). A 
summary of the new emerging /unknown viruses is given in Table 7.
Table 7  Summary of the new emerging /unknown viruses
Etiologic agents Disease
 Bocavirus
It was first discovered in 2005. It was classified 
in the family of Parvoviridae, subfamily 
Parvovinae, genus Bocavirus. Allender et al 
first showed that Bocavirus can be present 
in gastrointestinal tract in children with or 
without respiratory symptoms. Like other 
newly identified virus, there is no in vitro 
culture system.
Metapneumovirus
Van den Hoogen isolated the first human 
metapneumovirus from children experiencing 
RSV-like symptoms in 2001.The seropositivity 
is almost acquired in virtually all children by 
the age of 5 years of age.
Rhinovirus C
A variant rhinovirus has also been detected and 
shown to cause severe pneumonia. Rhinovirus, 
the most prevalent human respiratory pathogen, 
has in the past traditionally been attributed as 
a cause of upper respiratory tract infections, 
mostly common cold and concomitant acute 
otitis media episodes in infants and children. 
The recent detection, of rhinovirus species in 
its association with severe respiratory disease 
has strengthened and remotivated research 
interest in the clinical impact, molecular 
biology and epidemiology of this virus.   
❚❘❘ 50
Lower Respiratory Infections in Children
Influenza virus H1N1
A new strain of virus as a result of reassortment 
of viral genes from various different   sources. 
High density of human population co-mingling 
with animals from livestock activity (such as 
large concentration of pig farms and poultry) 
facilitates this process. The swine, known as an 
excellent blender mixes flu virus of different 
sources (Walsh,2011).This re assortment 
process was responsible for the emergent of 
the regional epidemic or global pandemic 
Influenza virus  A   H1N1 in 1918 , 1957 and 
1968  as well as  the deadly influenza virus 
H1N1 in  2009 (Osterhaus,2008) . During 
the assortment activity, exchange of genetic 
materials  took  place producing these  new 
strain of virus.
SARS coronavirus
Since the discovery of SARs coranovirus, 
there have been renewed interest in this virus 
and novel coranovirus have recently been 
discovered. These include coranovirus NL63 
(discovered in 2004) and HKU1. In 2003, the 
pandemic severe acute respiratory syndrome 
(SARS) was caused by a new emerging variant 
strain SARS coronavirus. It is now recognized 
that this strain had likely evolved from newly 
recognized animal SARs like coronavirus. The 
reservoir host of this animal like SARs are bats 
and it is believed through small mammals, man 
became the incidental host via international 
travel , this variant was transmitted to 26 
countries within a span of 9 months. 8098 
people were infected and 774 deaths were 
reported to WHO before the epidemic was 
declared over in July 2003 (Long,2008).
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 It is believed with improved state of the art diagnostic tools, 
more new pathogens previously undetected may be discovered. 
The detection of these viruses in respiratory samples suggests a 
viral contribution to respiratory symptomatology and pathology. 
Extensive research to discover new viruses is needed to close the 
gap of undiagnosed lower respiratory tract infections.
VIRAL INFECTION CAN BE FATAL
Viral infection of the lower respiratory tract most often is benign; 
however occasionally it can be fatal as described in our case report 
(Norlijah Othman et al, 2005).  This was a five-year-old, previously 
well obese girl, presented with acute shortness of breath after a 
history of ‘flu-like illness’. She was hyperglycaemic (condition in 
which glucose level in blood is high) and went into shock shortly 
after admission. The initial impression was diabetic ketoacidosis for 
which she was given fluid resuscitation. The hyperglycaemia was 
transient; it reverted to normal level without the administration of 
insulin infusion, the therapy for diabetic ketoacidosis.
 She rapidly deteriorated into hepatic failure, pancreatitis, 
myocarditis in heart failure and renal failure within 48hours of 
admission before she eventually succumbed. The only positive 
result was PCR for Enterovirus from the throat and rectal swab. The 
patient was thoroughly investigated for the possibility of infection, 
drug overdosage and metabolic disorder to establish the cause of 
this patient’s fatal clinical course. The only positive result was the 
polymerase chain reaction (PCR) for non-enterovirus 71, which was 
obtained on both throat and rectal specimens, suggesting a possible 
diagnosis of a coxsackie infection.  
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 Enteroviruses of human origin include polioviruses, coxsackie 
viruses of group A (types 1-24), coxsackie viruses of group B types 
1-6, echoviruses (1-34) and enteroviruses (types 68-71).  Most 
of these enteroviruses occur sporadically and are usually benign, 
although association with fatal cases is well documented. The 
unique clinical features of our case such as the rapidly fatal nature of 
the illness in the presence of myocardial failure and hyperglycemia 
mimicked to a certain extent the fatal cases reported during the 1997 
Malaysian outbreak of hand, foot and mouth disease attributed to 
EV 71 (K Shekar, 2005).However, the overwhelming simultaneous 
multiple organ involvement with a positive enterovirus but negative 
EV71 laboratory findings were in  favor of the diagnosis of a non-
EV 71 infection, possibly a coxsackie virus as it is known to cause 
pneumonia and hyperglycaemia with destruction of the β-islets of 
the pancreas.
 As a learning point, this report emphasizes the diversity of 
manifestations with fatal outcome in a viral infection involving the 
respiratory tract, even in a previously healthy child.
Viral Etiology and Clinical Features of Acute Lower 
Respiratory Tract Infections in Malaysia
This is the first study of an almost complete panel of the respiratory 
viruses using highly sensitive molecular methods among Malaysian 
children (N Othman, 2012). Previous local studies have used 
serology and the panel of viruses studied was on traditional ones. 
In this study the epidemiology, demographic and clinical features 
of respiratory viral infections were investigated among children 
less than five years hospitalized with acute LRI to Hospital 
Serdang, Malaysia. The cross-sectional survey was conducted at 
two 28-bedded pediatric wards, in Hospital Serdang, a government-
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funded multi-specialty hospital in the state  of  Selangor, Malaysia. 
Participants were children more than one-month-old and less than 
5 years of age who were admitted to the hospital from June to 
December 2009 with the diagnosis of acute LRI.
A panel of viruses was studied using molecular method-polymerase 
chain reaction (PCR) from the nasopharyngeal samples in children 
with acute LRI. The samples were detected for the established old 
viruses (RSV, rhinovirus A & B, parainfluenza1-4, influenza A & 
B, adenovirus and enterovirus) and the new, reemerging viruses 
(bocavirus, metapneumovirus, rhinovirus C and coranovirusOC43 
& 229E). All patients were investigated for presence of bacteria 
(bacterial culture) and Mycoplasma serology. 
 Children who met the final diagnosis for acute LRI were 
included in the study. However, children were excluded from the 
study if they had one of the following exclusion criteria: those 
with congenital or acquired immunosuppressive conditions; 
patients with conditions posing a potential hazard in obtaining the 
nasopharyngeal samples.For the majority of cases, chest x-rays were 
performed, reviewed and reported by an experienced radiologist.
Patient Demographic Characteristics
A total of one hundred and sixty five children were included in the 
study. Nearly in all virus groups male predominance was observed, 
supporting the other studies that acute respiratory infections are 
more common among males than females (overall male: female 
ratio 1.82:1). Majority of the patients were Malay (92.1%) followed 
by Chinese (4.8%) and Indian (3.0%).
 The mean age of the patients was 11.7 months, 64% in the first 
year of life (majority in the second half of the year) and 25% in the 
second year of age. The current study concurs with findings from 
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other studies that show the burden of hospitalization from viral LRI 
is 90% among young children <2 years old. Nearly one third of the 
enrolled children had at least one underlying co-morbid condition 
and asthma comprised of almost half of these patients.
Prevalence of Respiratory Viruses Among Children 
with LRI
Of 165 samples tested, at least one respiratory virus was detected 
in 158 of the 165 children implying a detection rate of 95.8%.The 
detection rate was extremely higher than those previously reported 
locally (Chan,1999; Zamberi, 2003) as the current study employed 
a more sensitive PCR method rather than serology to investigate 
the viral etiology for acute LRI. Furthermore, the previous studies 
were only confined to the old viruses, unlike the more extensive 
panel of viruses as in our study. However, Katherine E et al (2009) 
similarly reported a high detection rate of 89.9% using PCR on 
predominantly pediatric patients with acute respiratory infections 
in Brisbane.
 Table 8 shows virus frequencies. Single virus was detected in 
114 (67.9%) patients; 46 (27.9%) were co-infected with different 
viruses including double-virus infections in 37 (22.4%) and triple-
virus infections in 9 (5.5%) cases.
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Table 8   Virus frequencies
Virus Total infection
RSV 83 (50.3)a
HRV 54 (32.7)
HAdV 24 (14.5)
HMPV 16 (9.6)
IFV-A 15 (9.1)
PIVs 8 (4.8)
PIV-1 1 (0.6)
PIV-2 3 (1.8)
PIV-3 4 (2.4)
HBoV 6 (3.6)
HCoV-OC43 4 (2.4)
HEV 3 (1.8)
 Our study showed that RSV is still the commonest virus 
causing acute LRI (Etamedi MR, 2012) followed by rhinovirus and 
adenovirus in our local community. Previously, published findings 
have frequently confirmed RSV to be the major viral pathogen 
associated with LRI in children in both tropical and developing 
countries [WHO; 2009, Martin W, 1998].Rhinoviruses were also 
found to be associated with acute LRI at a relatively high rate, 
contradicting the traditional notion that this virus is mainly confined 
to upper respiratory infections. In constrast, bocavirus, coronavirus 
and parainflueza viruses were present at a low prevalence. We also 
reported for the first time the two new viruses, metapneumoviruses, 
bocavirus, (Etemadi MR et al 2011), rhinovirus C as possible causes 
of acute LRI among children in Malaysia (Etemadi MR, 2011). 
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Seasonal Distribution
The monthly distribution of cases with respiratory tract viruses 
is shown in Figure 11 and Figure 12. During the study period a 
continuously persisting activity was seen for RSV, rhinovirus, 
adenovirus and metapneumovirus. Outbreak of influenza A was 
from July to September, and peaked in August and plateaued 
from September onwards. RSV and rhinovirus peaked in October, 
an increase of cases was seen after the cease of the outbreak of 
influenza from September onwards. For the viruses with low 
prevalence, no distinct pattern is seen.
Figure 11   The monthly distribution of cases with respiratory tract 
viruses: RSV, HRV, HMPV and IFVA
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Figure 12   The monthly distribution of cases with respiratory tract 
viruses: PIV, HBOV, HEV, HCO-V
Clinical Characteristics
The clinical features of children who were tested for these viruses are 
summarized in Table 8. The age distributions of infants and children 
associated with each virus differed. LRI caused by RSV were 
predominant among younger infants (mean age, 9) compared with 
LRI associated with rhinovirus, metapneumovirus and influenza. 
In particular, a greater proportion of RSV infections occurred in 
infants <6 months old, compared with other virus-associated LRI. 
In addition, rhinovirus accounted for a large proportion of infants 
in the second half of the year. In contrast, influenza was frequently 
detected in older children of more than 1year old.
 The main clinical features of viral acute LRI are as shown in 
the bar chart (Figure 13). The more common clinical presentations 
found were cough (96%), fever (85%), rhinorrhea (83%), difficulty 
in breathing (84%), tachypnea, chest wall crepitations (93%) and 
recession (80%). Vomiting was the main non-respiratory symptoms 
in about half of the patients in this study population. As expected, 
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these features were no different from acute LRI caused by other 
non-viral pathogens such as bacteria. Fever, rhinorrhea and cough 
are also not specific for acute LRI as probably they are also present 
in upper respiratory infections (Kusel MMH, 2006).
Figure 13  Distribution of clinical features of study population
 Children were admitted to the hospital after a mean duration 
of 3 days after the onset of clinical symptoms which is consistent 
with other studies (WHO, 2009, Martin W, 2008). Our study 
showed that children infected with rhinovirus were hospitalized 
earlier in the course of their disease and were also less febrile on 
presentation as compared to the other highly prevalent infections-
RSV, metapneumovirus and influenza. The possible explanation 
for this observation is rhinovirus has shorter incubation period as 
compared with the other viruses. It is also the least invasive with 
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minimal cell damage and consequently secondary bacterial infection 
is far less a complication. As a result, patients with rhinovirus were 
less febrile and subjected to lesser antibiotics, thus stayed shorter 
in the hospital as seen in this study. 
 In the current survey, we found that patients infected with 
influenza seem to have more prominent symptom of diarrhea 
as compared to the other viruses. This could be attributed to 
the more systemic nature of this infection with direct invasion 
of the gastrointestinal system by the virus. The frequency for 
rhonchi (these are lung sounds, described as low-pitched sounds 
that resemble snoring and implies airway obstruction) was the 
same for all the viruses, whereas crepitations (these are lung 
sounds, described as a dry sound like that of grating the ends of a 
fractured bone) occurred more frequently in patients infected with 
metapneumovirus and influenza as compared to RSV or rhinovirus. 
These latter lung sounds (crepitations) were heard in all the low 
prevalent viruses in this study.
 In terms of laboratory findings, the white cell (a blood test to 
measure the number of white blood cells, a type of cell in the blood 
to fight against infection) and neutrophil cell counts (a type of white 
cell count that fights against infection) were higher in rhinovirus 
infection than in the RSV metapneumovirus and influenza. However, 
these abnormal blood counts may not reflect secondary bacterial 
infection in rhinovirus infection. Several studies in the past, 
acknowledged the increase neutrophils as a risk to development of 
asthmatic exacerbations.
 In this study, half of the chest X-ray was reported as abnormal. 
The low rate of abnormalities detected may be explained by the 
fact that chest x-ray may not be sensitive enough to show the whole 
profile of lung infiltrates as seen in adults with pneumonia (Lehtinen 
et al, 2007). A discrepancy between clinical and radiological 
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pneumonia was also observed in study by Peiris (2003) and it may 
represent the subjectivity of clinical observation. Peribronchial 
thickening (thickening surrounding the airway) is the most 
frequent findings as it denotes viral infection. In agreement with 
Wolf (2006), Calvo (2010) and Mullins (2004) the frequency of 
abnormal findings was similar among the different virus groups 
and no distinctive differences were noted.
Hospital Course
Oxygen was administered to almost three fourths of the patients 
which were found higher than that the previous literature (Miller 
E, 2007). It seems possible that the higher frequency need for 
supplemental oxygen could be the presence of more patients with 
underlying medical condition in the study population. Another 
possibility may be due to the occurrence of bacterial culture-
negative co-infections. Three of the patients required ventilation 
for 3-7 days; two had single infection of rhinovirus and RSV 
respectively while the other has dual RSV and adenovirus infection. 
No death was reported in this study.
 The most common discharge diagnosis among all the 
children infected was pneumonia, followed by bronchiolitis. RSV 
followed by rhinovirus was more likely to cause bronchiolitis, and 
metapneumovirus followed by influenza showed a tendency to 
cause pneumonia. RSV is known traditionally as the major cause 
of bronchiolitis in children, whereas the importance of rhinovirus 
in contributing to the etiology of LRI has emerged over the past 
one decade with the introduction of PCR as a diagnostic research 
tool. Metapneumovirus, the new emerging virus, has also been 
increasingly recognized on its role in LRI. Previous studies has 
shown varying burden of this new virus as a cause of pneumonia 
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or bronchiolitis. The differences in observation could reflect 
differences in diagnostic definitions or study populations between 
reports. 
 
CONCLUSION 
Our results suggested that respiratory viral agents significantly 
contributed to the etiology of acute LRIs among hospitalized 
children. Majority occurred among children less than 2 years 
of age demonstrating the notion that the burden of respiratory 
infections is high among this age group of patients. RSV is still the 
commonest virus causing acute LRI followed by rhinovirus in our 
local community. The new viruses such as metapneumovirus and 
bocavirus also contributed to the causes of acute LRI. 
 PCR method employed in this study permitted the detection of 
many viruses and allows us to have a broader insight of the viruses 
implicated in LRI. Our study has limitations. It was based on an 
analysis of samples from cases with acute LRI in a hospital based. 
Therefore we could not determine the population-based prevalence. 
Other limitations include there was no control and a qualitative 
assay rather than quantitative was used. This may not reflect the 
true incidence of the actual infection as some viruses are known 
to harbor in the respiratory tract for a long time, without causing 
infection.
OTHER PATHOGENS
A variety of organisms and host factors prompt consideration of 
specific organisms. The most important of these is Mycobacterium 
tuberculosis (MTB), which should always be suspected if there 
is a history of exposure, in the presence of typical chest x-ray 
changes compatible with the infection (eghilaradenopathyie lymph 
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enlargement around the hilar area of the lungs) or when pneumonia 
does not respond in a typical fashion to therapy or with passage 
of time. 
MTB in Children
Tuberculosis (TB) is usually a primary disease of children, and the 
dissemination of the infectionwith its attendant risk of mortality 
can be rapid. Early diagnosis is very important but unfortunately 
difficult. The “gold standard” method of diagnosis of TB is culture. 
Unfortunately, this is rarely obtained in children with TB disease 
because of the paucibacillary nature of the illness. Furthermore, a 
culture takes a longer time, which limits its usefulness in the initial 
diagnosis. At best, only 30-50% of cases of tuberculosis in children 
are confirmed by culture (Shingadia and Novelli, 2003), while 30% 
could be Mantoux negative (Lokman, 1994). Furthermore, the lack 
of characteristic symptoms in a majority of children, in comparison 
to adults, makes TB difficult to be diagnosed in the former group.
 In an endemic area such as Malaysia, a diagnosis of TB should 
always be entertained in a clinical setting when there is poor clinical 
response to conventional anti-microbial therapy. Even with an 
unusual presentation (Norlijah O, 2007), in the presence of a negative 
culture and Mantoux as well as in an absence of contact with other 
tuberculous patients, TB infection should also be considered as a 
possible infection.  In such a clinical scenario, TB PCR is a useful 
adjunct tool for a definite diagnosis. (Norlijah O et al, 2006). It is 
rapid, highly specific, although less sensitive, especially from sterile 
body fluids and can add to the overall decision-making process 
when considered in tandem with appropriate clinical findings. 
 Clinicians should be more perseverant and open in the pursuit 
of the diagnosis; otherwise, delayed diagnosis and treatment could 
be detrimental to a patient’s life, leading to increased morbidity and 
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mortality. Furthermore, TB has been under-diagnosed in endemic 
countries such as Malaysia, because most young doctors expect 
the skin sensitivity or smear for AFB tests to be positive before 
treatment would be initiated. Such practices have resulted in 30% 
of TB deaths to be diagnosed at post-mortem (Hooi, 1994)
Pertussis
Pertussis is a highly contagious bacterial disease of the respiratory 
system caused by Bordetellapertusis. In some countries, this disease 
is commonly called whooping cough, is also called the 100 days’ 
cough or cough of 100 days. It mainly affects infants younger than 
6 months old before they’re adequately protected by immunizations, 
and children 11 to 18 years old whose immunity has started to fade
 Initial symptoms, similar to the common cold usually develop 
about a week after exposure to the bacteria. Severe characteristic 
episodes of coughing, which last for one to two minutes, typically 
described by mum ‘the face of her child turning red or purple’. 
This coughing spells start about 10 to 12 days later. In a more life 
threatening episode, the child may actually stop breathing (called 
apnea) for a few seconds during these particularly bad spells. In older 
children, the coughing often ends with a “whoop” noise. The sound 
is produced when the patient tries to take a breath. The whoop noise 
is rare in patients under 6 months of age and in adults. Coughing 
spells may lead to vomiting or a short loss of consciousness. 
Pertussis should always be considered when vomiting occurs with 
coughing, and in the presence of the classical characteristic cough 
especially in children with incomplete immunization ( Norlijah 
O et al, 2005). Adults and teens with whooping cough may have 
milder or atypical symptoms, such as a prolonged cough (rather 
than coughing spells) or coughing without the whoop.
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 Many experts believe that the medication is most effective in 
shortening the duration of the infection when given in the first stage 
of the illness, before coughing spells begin. But even if antibiotics 
are started later, they’re still important because they can stop the 
spread of the pertussis infection to others. Infants and younger 
children are more likely to be hospitalized because they are at 
greater risk for complications such as pneumonia, which occurs in 
about 1 in 5 children under the age of 1 year who have pertussis. 
 Before a vaccine was available, pertussis killed 5,000 to 10,000 
people in the United States each year. Now, the pertussis vaccine 
has reduced the annual number of deaths to less than 30. But in 
recent years, the number of cases has started to rise. By 2004, the 
number of whooping cough cases spiked past 25,000, the highest 
level it’s been since the 1950s.
Fungal Infections
In immunocompromised children, fungal infections should be 
highly considered as a cause of pneumonia. It can be caused by 
either endemic or opportunistic fungi or a combination of both. 
Case mortality in fungal pneumonias can be as high as 90% 
in immunocompromised patients, though immunocompetent 
patients generally respond well to anti-fungal therapy.
 Residence in or travel to certain geographic areas suggests 
consideration of certain pathogens. Coccidiides immitis is endemic 
in the Southwest United States, northern Mexico, and parts of 
Central and South America. Histoplasma capsulatum is endemic 
in United States and Canada.  Pneumocystis jirovecci (P. carinii) 
causes pneumonia in HIV-infected infants at 3-6 months, in 
severely malnourished children and immunocompromised hosts. 
Penicillium marneffei is reported predominant in Thailand and 
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particularly Thailand where it has become the third defining illness 
defining AIDS. Due to the lagging behind of the AIDS epidemics 
in Malaysia as compared to Thailand, penicilliosis cases are seen 
sparingly especially in children (O. Norlijah, 2004)
Other Rarer Pathogens
Pseudomonas pseudomallei (melioidosis) is of public health 
importance in endemic areas, particularly in Thailand, Malaysia 
and northern Australia and the organism is found in soil and 
water (Norlijah Othman, 2007). Some other pathogens, 
Chlamydophiliapsitaci, Coxiellaburnetii and Francisellatularensis 
are infected from infected birds, animals or humans.  Legionella 
pnemophila is a rare cause of pneumonia in children but is considered 
with certain environmental exposures and in immunocompromised 
individuals. Pneumonia in leptospirosis, on occasion may be 
dramatic and is associated with a more severe form of infection 
with multiple organ involvement (Norlijah Othman et al, 2007). 
Figure 14  Chest x-ray showing bilateral effusion; the child with 
leptospirosis
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Figure 15  Icthyosis, a skin condition, first case reported associated 
with leptospirosis
 Typhoid, a common worldwide bacterial disease, transmitted 
by the ingestion of food or water contaminated with the feces of 
an infected person, which contain the bacterium Salmonella typhi, 
rarely causes pneumonia (Othman N, 2003).
FUTURE DIRECTIONS-THE WAY FORWARD
Lower respiratory infections continue to threaten the health of 
children worldwide as it continues to be the major killer in children, 
especially in developing countries. It is estimated that 3.9 million 
children die each year from acute respiratory infections (WHO, 
2009).This large mortality, which virtually goes unnoticed, has been 
described as being equivalent to a jumbo jet carrying 400 children 
crashing every hour, day after day. The outcomes of LRI illness 
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are far better in developed countries, but the overall morbidity of 
LRI is still high and may exceed that of other age groups. It is also 
clear that further progress in preventing, diagnosing and treating 
LRI diseases will have an impact on the health of a child. 
 There is still a gap in information on the burden of LRI in 
developing countries as compared to developed countries. LRI are 
much studied in developed countries and their impact on health 
care is well understood. From the public health point of view, it 
would be valuable to know the causative agents, what their disease 
manifestations are, what interplay between viruses and bacteria and 
to institute intervention strategies to prevent future infections. It is 
now the time to plan studies that would determine the burden of LRI 
in the developing world. The ongoing PERCH (Pneumonia Etiology 
Research for Child Health), a comprehensive multinational study, 
evaluating etiology of pneumonia and its associated risk factors is 
an on-going multi-centred ( at seven sites) worldwide study, will 
throw some light on this problem in the near future(Gilani Z et al, 
2012).
 Standard care management has been the primary strategy 
suggested by WHO for reduction of pneumonia mortality (Stephen 
MG, 2008). The simple guidelines developed by the WHO for early 
detection and treatment of pneumonia have been tested to reduce 
acute LRI mortality in children, but not adequately utilized.  Delayed 
in seeking medical treatment by parents/guardians and failure to 
recognize LRI signs/symptoms in children by medical practitioners/
health workers are the reasons for the above strategy not to succeed 
in total.
 The key dilemma for clinicians is to distinguish between 
bacterial and viral LRI disease(Jean EK, 2003). The great majority 
of respiratory infections are of viral origin. However, 10-50% 
of patients will develop secondary infections. Depending on the 
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clinical setting, various tests are may be available to evaluate a child 
with LRI disease. Yet no specific test, or panel of tests, consistently 
differentiates viral from bacterial LRIs. Moreover, co-infection 
with both virus and bacteria may occur. Clinical, radiological or 
non-specific laboratory findings are not sufficiently sensitive and 
specific for separating between viral, bacterial or atypical bacterial 
pneumonia, as observed in many population-based, hospital based 
outpatient and hospital-based inpatient studies (Mullins 2004, Wolf 
2006, Calvo 2010). For that reason, studies continue to document the 
overuse of antibiotics for treatment of LRI’s in children, especially 
those who are hospitalized (Niang et al, 2010). The widespread use 
of antibiotics likely reflects the clinical problem of differentiating 
bacterial from viral LRI disease, as well as the potential risks of 
bacterial LRI illness. Improved techniques to detect bacterial and 
viral pathogens remain a challenge for future researchers to ease 
the healthcare providers’ burden in interpreting signs and symptoms 
of LRI diseases that are often clinically indistinguishable.
 The difficulty in the identification of the causative agent of LRI 
in children remains challenging for a couple of reasons: endotracheal 
aspirates cannot be obtained routinely, nasopharangeal swabs only 
show colonization by normal flora including the bacteria most 
commonly causing pneumonia, and bacteremia is demonstrated 
in less than 10% of bacterial community acquired pneumonia.. 
Therefore, the etiology of LRI especially in pneumonia remains 
often unknown, with the consequence that many children get an 
antibiotic treatment from non-bacterial infections, contributing to 
the increase of bacterial resistance to antibiotics. 
 There is also a growing problem of resistance to antimicrobial 
agents and the spread of this trait is global. Examples are penicillin-
resistant S. pneumoniae, emergence of vancomycin-resistant S. 
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aureus and multi-drug resistant tuberculosis continue to increase 
worldwide.  The resistance pattern is not only confined to bacteria 
but of late atypical bacteria- macrolide-resistant M. pneumoniae 
and influenza virus- ometalvir-resistant to Influenza virus have been 
reported.  
 Various factors have been identified to be responsible for the 
emergence and spread of resistant microorganism. These include 
irrational and self-use of antimicrobials, lack of adherence to 
prescribed regimen, wide spread non-human use of antibiotics 
and other anti-infective agents, increased use of antimicrobials, 
especially antibiotics in immunocompromised and critically ill 
patients. The problem is further compounded by poor prescribing 
habit of doctors. The key factor is widespread, indiscriminate use 
of antimicrobials. 
 Increases in the incidence for antimicrobial resistant community 
acquired pneumonias pose a major challenge to health care 
providers. The resistant organisms are not only difficult to treat; 
they also impose great health risks to individuals and significant 
costs to society. The resistant organisms have the potential of 
spreading to non-hospital environments, so that the problem which 
was initially encountered in hospital settings is now increasingly a 
community problem as well. For this reason, the World Economic 
Forum has included antibiotic resistance in its 2013 Global Risks 
report recently.
 Effective and rigorous surveillance system has been put in 
place in some countries to track emergence and spread of resistance 
to antimicrobials. Such surveillance has been able to bring about 
changes in national policies and practices. Other measures include 
generating grants for research to identify genetic mechanisms 
for antibiotic resistance, encourage pharmaceutical companies 
in search for new antimicrobials, judicious prescription and use 
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of antimicrobials and simple hygienic practices at home and 
particularly when visiting hospitals, such as hand-washing, are 
all key and important ways to formulate strategies to combat the 
increasing antimicrobial resistance. 
 With the availability of PCR, it is now possible to detect 
new pathogens such as metapneumovirus, bocavirus, the novel 
coronavirus and rhinovirus-C’s, thereby allowing for better 
definition of certain LRI illnesses in the clinical setting. On 
the other hand, the clinical interpretation of the detection of a 
virus from nasopharangeal secretions in a child with LRI can be 
challenging. Viral quantification may prove helpful to determine 
when an isolate is associated with severe disease. Several superior 
molecular typing also differentiates CA-MRSA against HA-MRSA, 
which can be used for supporting nosocomial infections; in tracing 
the nosocomial sources and transmission routes of the bacterial 
pathogen.
Preventive Strategies 
•	 Targeting vaccinations 
 Vaccination against Hib and pneumoccocal diseases has shown 
an impact on the incidences of the related pneumonias in 
developed countries where extensive immunization is being 
implemented. The benefits from both vaccinations include: 
individual immunity from the disease, herd immunity from 
the disease, and simplified treatment regimens as antimicrobial 
resistance is being reduced. For instance, vaccine probe studies 
from developing countries with high disease burden from Hib 
infections have demonstrated a 20-30% reduction in “x-ray 
documented pneumonias in children less than 3 years old 
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vaccinated against Hib (Russel FM 2003, de Andrade Al, 
2004)  ). The widespread use of both vaccines has already 
altered the spectrum of community acquired pneumonia in 
children, and more global use of these vaccines may reduce 
(or eliminate) the risk of antimicrobial resistant bacterial LRI. 
However, issues of cost and distribution of both vaccines to 
the developing countries remain the key obstacles for the 
vaccines to be available worldwide. Likewise, vaccines for 
other major causes of childhood pneumonia such as influenza 
will likely become more widely used across the globe or may 
be successfully developed (eg RSV) over the next decade, and 
therefore will further influence the pneumonia burden and 
remaining etiologies.
•	 Effective health education of the community and appropriate 
initiatives taken by the government to address the known risk 
factors including various socio-demographic, nutritional and 
environmental,  associated with LRI, leading to a healthy 
community and nation well-being. Improvement in global 
socioeconomic conditions will influence the pneumonia 
etiologic spectrum in the future. 
•	 Well-written policies to be in place for any outbreaks.
While there is much scope for further research, it is also 
imperative that all efforts be made to effectively implement 
strategies which have been shown to have a definite impact on 
LRI mortality in order to reduce the high mortality especially 
in developing countries. The responsibility for this does not lie 
with the government agencies alone but requires the concerted 
and sincere effort of all those involved in health care.
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BIOGRAPHY
Professor Dr Norlijah Othman was born in Tampin, N. Sembilan 
in 1961. She received her formal education in Tunku Besar School 
and secondary education in Sekolah Menengah Sains Tunku Jaafar, 
Kuala Pilah.  She was active in sports – a state netball player and 
actively took part at the district sprint events. Even at  university, 
she continued to participate actively in games for the faculty. Her 
favourite subject has always been in Mathematics and she always 
wanted in her early days to take up a career in either actuarial science 
or computer. However, on persuasion from both parents, she took up 
Medicine instead and has never regretted making such a decision. 
 She completed her MBBS (Mal) at the University of Malaya 
in 1986. She obtained her MRCP (UK) at the Royal College of 
Physicians in United Kingdom in 1992. A young paeditrician at 
30,  she worked for a while in Bristol United Kingdom and later 
in Hospital Sultanah Aminah, Johor Bahru.  Her special interest 
in Infectious Diseases, has driven her towards pursuing her 
subspecialty training as a fellow in Infectious Diseases in 1996 at 
the prestigious Great Ormond Street Hospital in London.
 Upon returning from her subspeciality training, she was based 
in Institute of Paediatrics, Hospital Kuala Lumpur as the Head of 
Paediatric Infectious Disease in the hospital.  During her short stint 
as a Specialist in Paediatric Infectious Diseases with Ministry of 
Health, she was involved in the setting of several existing national 
policies in relation to infectious diseases.  Among the major ones 
include the setting up of the national policy for i) provision of 
antiretroviral therapy in HIV children and injectable (SABIN) and 
Hib vaccinations to be made available to these children and ii) 
perinatal maternal-child transmission in HIV (ACTG protocol), 
which was piloted in 1998 and now is part of the public health 
programme for antenatal mothers/babies. She was also very much 
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involved in the first major EV 71 outbreak in Malaysia, which 
started in Sibu, Sarawak in 1998.   She was one of the collaborators 
of all acute fatalities in children during the outbreak in Peninsula 
Malaysia and was also responsible for drawing up a protocol for 
suspected fatalities during the outbreak period.
 1999 was a major turning point in her career development when 
she joined Universiti Putra Malaysia as an Associate Professor 
and later promoted to a Professor in July 2007. She was the Unit/ 
Department Head from 2000 onwards. Being a pioneer, she has 
helped to establish the undergraduate Paediatric program and further 
improved it in the later years. Her other pioneering projects during 
her headship was organizing and establishing the Paediatric services 
both in Hospital Kuala Lumpur and later in Hospital Serdang. 
 In August 2010, she was appointed the Dean of the Faculty 
of Medicine and Health Sciences, an administrative post that 
she currently holds. During her Deanship, she has gained several 
accomplishments to her credit. She has helped to procure the 
RM600 million allocation for the new 400-bedded teaching hospital, 
set up the Family Medicine private clinic, put up the 5 new Masters 
Medicine program of the different fields  mobilize the academic staff 
under on administrative centre and improved the working benefits 
and infrastructure for the betterment of the faculty and the staff. She 
has also  intensified the community engagement program such as 
the Program Anak Angkat and Kem Kesihatan at Pagoh and Pasir 
Gudang. 
  As a Pediatric infectious disease specialist and being the 
first two to be formally trained in this area of subspecialty in the 
country, she has been one of the four committee members for the 
National Specialist  Registrar since it was established. She has been 
responsible in formalizing the three-year training program for the 
country. She was appointed as a visiting consultant for National 
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Health Institute (IJN),  providing consultations on infectious-related 
cases before she became the Dean in 2010. She had the opportunity 
to further her subspecialty training in three other renowned centres 
apart from Great Ormond Street Hospital. The others include 
University of Sydney, Australia, University of Chulalongkorn, 
Thailand and latest was University of John Hopkins, Baltimore, 
USA.   
 Despite her hectic schedule as a Dean, she still finds time 
teaching which she enjoys immensely in guiding the students, 
giving invaluable advice to them and mentoring them on ‘hands on’ 
examination on patients.  She also finds it is a pleasure talking and 
communicating with her patients during ward-rounds. In terms of 
research, she was involved in 27 research projects where she was 
the project leader for 10 of these projects. In the field of publication, 
she has written in more than 100 publications. Her publications 
include among others 43 publications in journal, 55 proceedings at 
international and national level, 10 articles related to pediatrics in 
general in family magazines, and 4 modules. This does not include 
working papers/modules, which she is actively involved.
 Professor Norlijah Othman, feels as an infectious disease 
specialist, there are more horizons to venture especially in terms 
of scope of research as Malaysia still lacks the basic data in this 
area. Research collaboration has to be intensified to yield more 
useful results. As a Dean of the Faculty, she is of the opinion that 
the faculty has a lot of potentials yet to be tapped and improved 
especially in terms of education & curriculum, research & 
publication internationalization, industrial linkages & community 
engagement and income generation.  She believes the faculty can 
be one of the best in the region.
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